Neos Therapeutics, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/20 Q3

ended 06/30/20 Q2

ended 03/31/20 Q1

ended 12/31/19 FY 2019

ended 09/30/19 Q3

Prospectuses and Registrations Filter

Securities registration termination

Business combination disclosure

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Limongelli John M

Robinson James A. Jr.

McLaughlin Gerald W.

News Filter

Aytu BioScience Announces Close of Merger With Neos Therapeutics

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Gerald McLaughlin (Chief Executive Officer of Neos Therapeutics, Inc.) Slide 4

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Financial Statements or Exhibits

Investor Presentation

Proxies Filter

Additional info about upcoming vote

Proxy related to merger

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness